# Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip

> **NCT03405974** · PHASE3 · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 114 (estimated)

## Conditions studied

- Osteonecrosis of Femoral Head
- Osteonecrosis; Aseptic, Idiopathic

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03405974
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-12
- **Primary completion:** 2020-11-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2018-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03405974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03405974, "Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03405974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*